Performance evaluation of the new HIV-1 quantification assay, Xpert HIV-1 viral load, on a wide panel of HIV-1 variants

Journal of Acquired Immune Deficiency Syndromes

Volumn 72, Issue 5, 2016, Pages 521-526

  Gueudin, Marie ^a,b   Baron, Adeline ^a   Alessandri Gradt, Elodie ^a,b   Lemée, Véronique ^a   Mourez, Thomas ^a,b   Etienne, Manuel ^b,c   Plantier, Jean Christophe ^a,b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c HÔPITAL CHARLES NICOLLE   (France)

Author keywords

genetic diversity; GeneXpert; HIV viral load

Indexed keywords

VIRUS RNA; DIAGNOSTIC KIT;

CONFERENCE PAPER; CONTROLLED STUDY; EVALUATION STUDY; GENETIC VARIABILITY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SUPERNATANT; VIRAL LOAD ASSAY; VIRUS DETECTION; VIRUS LOAD; VIRUS TYPING; DIAGNOSTIC KIT; GENETIC VARIATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS; VIROLOGY;

GENETIC VARIATION; HIV INFECTIONS; HIV-1; HUMANS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 84961392249     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000001003     Document Type: Conference Paper

References (16)

1. Labbett W, Garcia-Diaz A, Fox Z, et al. Comparative evaluation of the exavir load version 3 reverse transcriptase assay for measurement of human immunodeficiency virus type 1 plasma load. J Clin Microbiol. 2009; 47: 3266-3270
2. Bourlet T, Signori-Schmuck A, Roche L, et al. HIV-1 load comparison using four commercial real-time assays. J Clin Microbiol. 2011; 49: 292-297
3. Garcia-Diaz A, Labbett W, Clewley GS, et al. Comparative evaluation of the artus HIV-1 QS-RGQ assay and the abbott realtime HIV-1 assay for the quantification of HIV-1 RNA in plasma. J Clin Virol. 2013; 57: 66-69
4. Mourez T, Delaugerre C, Vray M, et al. Comparison of the bioMerieux nucliSENS easyQ HIV-1 v2.0-HIV-1 RNA quantification assay versus abbott realtime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants. J Clin Virol. 2015; 71: 76-81
5. Hopkins M, Hau S, Tiernan C, et al. Comparative performance of the new Aptima HIV-1 quant dx assay with three commercial PCR-based HIV-1 RNA quantitation assays. J Clin Virol. 2015; 69: 56-62
6. Sire JM, Vray M, Merzouk M, et al. Comparative RNA quantification of HIV-1 group M and non-m with the roche cobas ampliPrep/cobas taqMan HIV-1 v2.0 and abbott real-time HIV-1 PCR assays. J Acquir Immune Defic Syndr. 2011; 56: 239-243
7. Raja S, Ching J, Xi L, et al. Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin Chem. 2005; 51: 882-890
8. Mourez T, Simon F, Plantier JC. Non-M variants of human immunodeficiency virus type 1. Clin Microbiol Rev. 2013; 26: 448-461
9. Plantier JC, Dachraoui R, Lemee V, et al. HIV-1 resistance genotyping on dried serum spots. AIDS. 2005; 19: 391-397
10. Mor O, Gozlan Y, Wax M, et al. Evaluation of the realTime HIV-1, xpert HIV-1, and aptima HIV-1 quant dx assays in comparison to the nucliSens easyQ HIV-1 v2.0 assay for quantification of HIV-1 viral load. J Clin Microbiol. 2015; 53: 3458-3465
11. Gueudin M, Leoz M, Lemee V, et al. A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection. J Clin Microbiol. 2012; 50: 831-836
12. WHO. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. World Health Organization, Geneva, Switzerland. 2013
13. Essajee S, Kumarasamy N. Commentary: the monitoring of adults and children on antiretroviral therapy in the 2013 WHO consolidated ARV guidelines. AIDS. 2014; 28(suppl 2): S147-S149
14. European AIDS Clinical Society (EACS) Guidelines Version. Available at: www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html. Accessed on October 8, 2015
15. Recommandations du groupe dexperts. Prise en charge médicale des personnes vivant avec le VIH. Sous la direction du Pr Morlat; La documentation Française, Paris, France. 2013
16. Marcelin AG, Delaugerre C, Beaudoux C, et al. A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure. Int J Antimicrob Agents. 2013; 42: 42-47